Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00125242 · ClinicalTrials.gov registry record · NA
Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis
A NA study of Aphasia and Language Disorders, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT00125242: Completed NA study of Aphasia and Language Disorders, sponsored by US Department of Veterans Affairs.
NCT00125242 is a NA study of Aphasia and Language Disorders that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 110 participants, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00125242, a NA study of Aphasia and Language Disorders, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this investigation is to further develop and test a treatment for word-finding problems in aphasia. The treatment is designed to strengthen meaning associations within categories of words (e.g., animals, tools, fruits). The treatment is also designed to be used as a search strategy in instances of word-finding difficulty. The study was devised to evaluate the extent to which treatment increases the ability to recall trained, as well as untrained, words.
Primary Outcome
Accuracy of naming of pictured treated and untreated items was assessed in probes conducted separate from treatment. Probes were conducted repeatedly throughout the study, from baseline (prior to treatment) to follow-up (6 weeks following treatment). All naming responses were scored using a 0-10 scale reflecting promptness and presence of errors; scores of 8-10 received an "accuate" score and scores of 0-7 received an "inaccurate" score. A percentage accuracy score was calculated for each experi
Conditions Studied
Interventions
- BEHAVIORAL Semantic Feature Analysis (SFA)Training
Study Locations (1)
Utah
- VA Salt Lake City Health Care System, Salt Lake City - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT00125242 record still lists
NCT00125242 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (36% higher).
The record links to 3 conditions, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Semantic Feature Analysis (SFA)Training is the first listed.
NCT00125242 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT00125242 about?
NCT00125242 is a clinical study titled "Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis". The purpose of this investigation is to further develop and test a treatment for word-finding problems in aphasia. The treatment is designed to strengthen meaning associations within categories of words (e.g., animals, tools, fruits). The treatment is also designed to be used as a search strategy in...
What is the current status of trial NCT00125242?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2005-07. Estimated completion is 2013-04.
What conditions does trial NCT00125242 study?
This clinical trial studies the following conditions: Aphasia, Language Disorders, Speech Disorders.
What interventions are being tested in trial NCT00125242?
The interventions under investigation include: Semantic Feature Analysis (SFA)Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00125242?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00125242 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00125242's enrollment target sits among peer trials
110 11th of 42 higher than 32 of 42 other Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia